La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.

Identifieur interne : 002D53 ( Main/Exploration ); précédent : 002D52; suivant : 002D54

Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.

Auteurs : Fiona E. Parkinson [Canada] ; Jessica Friesen ; Ljiljana Krizanac-Bengez ; Damir Janigro

Source :

RBID : pubmed:12867263

English descriptors

Abstract

Extracellular adenosine is produced in brain during physiological and pathophysiological conditions. Once produced, this adenosine can undergo one or more of the following fates: it can interact with its receptors, it can be scavenged by astrocytes and/or neurons for ATP resynthesis, it can be transported across the blood-brain barrier and lost from the central nervous system, or it can be metabolized to inosine and hypoxanthine. The present study used a three-dimensional in vitro cell culture model of the rat blood-brain barrier, in which forebrain astrocytes and microvascular endothelial cells were cultured in cartridges containing multiple parallel polypropylene hollow fibers. Endothelial cells were cultured on the inner surfaces and astrocytes on the outer surfaces of these fibers. Growth medium was constantly perfused through the lumen of the fibers to mimic blood flow across endothelial cells in vivo. This co-culture system was used to examine the permeation of adenosine, and its metabolite inosine, from the astrocyte compartment to the endothelial cell compartment. Dipyridamole was added to the media perfusing the endothelial cell compartment to test whether it could decrease permeation of adenosine and inosine across the in vitro blood-brain barrier. Our results indicate that dipyridamole decreased permeation of total purines, especially inosine, across the barrier. Furthermore, permeation of fluorescein isothiocyanate-labeled albumin and radiolabeled sucrose, markers of the paracellular permeation pathway, were also decreased by dipyridamole. In conclusion, these data indicate that in addition to inhibiting nucleoside efflux across the barrier, dipyridamole can also improve blood-brain barrier function in this model.

PubMed: 12867263


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.</title>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology, University of Manitoba, A403, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada. parkins@ms.umanitoba.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology, University of Manitoba, A403, 753 McDermot Avenue, Winnipeg, MB R3E 0T6</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Friesen, Jessica" sort="Friesen, Jessica" uniqKey="Friesen J" first="Jessica" last="Friesen">Jessica Friesen</name>
</author>
<author>
<name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</author>
<author>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12867263</idno>
<idno type="pmid">12867263</idno>
<idno type="wicri:Area/PubMed/Corpus">001420</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001420</idno>
<idno type="wicri:Area/PubMed/Curation">001420</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001420</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001420</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001420</idno>
<idno type="wicri:Area/Ncbi/Merge">000319</idno>
<idno type="wicri:Area/Ncbi/Curation">000319</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000319</idno>
<idno type="wicri:doubleKey">0006-8993:2003:Parkinson F:use:of:a</idno>
<idno type="wicri:Area/Main/Merge">003126</idno>
<idno type="wicri:Area/Main/Curation">002D53</idno>
<idno type="wicri:Area/Main/Exploration">002D53</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.</title>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology, University of Manitoba, A403, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada. parkins@ms.umanitoba.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology, University of Manitoba, A403, 753 McDermot Avenue, Winnipeg, MB R3E 0T6</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Friesen, Jessica" sort="Friesen, Jessica" uniqKey="Friesen J" first="Jessica" last="Friesen">Jessica Friesen</name>
</author>
<author>
<name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</author>
<author>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
</author>
</analytic>
<series>
<title level="j">Brain research</title>
<idno type="ISSN">0006-8993</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine (metabolism)</term>
<term>Animals</term>
<term>Astrocytes (cytology)</term>
<term>Astrocytes (metabolism)</term>
<term>Biological Transport</term>
<term>Blood-Brain Barrier (physiology)</term>
<term>Brain (cytology)</term>
<term>Brain (metabolism)</term>
<term>Cell Culture Techniques (methods)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Endothelium, Vascular (cytology)</term>
<term>Endothelium, Vascular (metabolism)</term>
<term>Models, Biological</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adenosine</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Astrocytes</term>
<term>Brain</term>
<term>Endothelium, Vascular</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Astrocytes</term>
<term>Brain</term>
<term>Endothelium, Vascular</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Cell Culture Techniques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Blood-Brain Barrier</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Biological Transport</term>
<term>Dose-Response Relationship, Drug</term>
<term>Models, Biological</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Extracellular adenosine is produced in brain during physiological and pathophysiological conditions. Once produced, this adenosine can undergo one or more of the following fates: it can interact with its receptors, it can be scavenged by astrocytes and/or neurons for ATP resynthesis, it can be transported across the blood-brain barrier and lost from the central nervous system, or it can be metabolized to inosine and hypoxanthine. The present study used a three-dimensional in vitro cell culture model of the rat blood-brain barrier, in which forebrain astrocytes and microvascular endothelial cells were cultured in cartridges containing multiple parallel polypropylene hollow fibers. Endothelial cells were cultured on the inner surfaces and astrocytes on the outer surfaces of these fibers. Growth medium was constantly perfused through the lumen of the fibers to mimic blood flow across endothelial cells in vivo. This co-culture system was used to examine the permeation of adenosine, and its metabolite inosine, from the astrocyte compartment to the endothelial cell compartment. Dipyridamole was added to the media perfusing the endothelial cell compartment to test whether it could decrease permeation of adenosine and inosine across the in vitro blood-brain barrier. Our results indicate that dipyridamole decreased permeation of total purines, especially inosine, across the barrier. Furthermore, permeation of fluorescein isothiocyanate-labeled albumin and radiolabeled sucrose, markers of the paracellular permeation pathway, were also decreased by dipyridamole. In conclusion, these data indicate that in addition to inhibiting nucleoside efflux across the barrier, dipyridamole can also improve blood-brain barrier function in this model.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Manitoba</li>
</region>
<settlement>
<li>Winnipeg</li>
</settlement>
<orgName>
<li>Université du Manitoba</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Friesen, Jessica" sort="Friesen, Jessica" uniqKey="Friesen J" first="Jessica" last="Friesen">Jessica Friesen</name>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
<name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</noCountry>
<country name="Canada">
<region name="Manitoba">
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D53 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002D53 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:12867263
   |texte=   Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:12867263" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022